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Abstract 
 
Nutrigenomics is an emerging discipline that aims to investigate how individual 
genetic composition correlates with dietary intake as well as how nutrition influences gene 
expression. Herein, the fundamental question relates to the value of nutrigenomics testing 
on the basis of the currently available scientific evidence. A thorough literature search has 
been conducted in PubMed scientific literature database for nutrigenomics research studies 
on 38 genes included in nutrigenomics tests provided by various private genetic testing 
laboratories. Data were subsequently meta-analysed to identify possible associations 
between the genes of interest and dietary intake and/or nutrient-related pathologies. Data 
analysis occurred according to four different models due to data sparsity and inconsistency. 
Data from 524,952 individuals (361,153 cases and 163,439 controls) in a total of 1,170 
entries were obtained. Conflicting findings indicated that there was a great incompatibility 
regarding the associations (or their absence) identified. No specific - and statistically 
significant - association was identified for any of the 38 genes of interest. In those cases, 
where a weak association was demonstrated, evidence was based on a limited number of 
studies. As solid scientific evidence is currently lacking, commercially available 
nutrigenomics tests cannot be presently recommended. Notwithstanding, the need for a 
thorough and continuous nutrigenomics research is evident as it is a highly promising tool 
towards precision medicine. 
 
Keywords: nutrigenomics, nutrigenomics testing, dietary intake, nutrition, genes, meta-
analysis. 
Introduction 
Nutrigenomics is an emerging discipline that aims to investigate how individual 
genetic composition correlates with dietary intake as well as how nutrition influences gene 
expression (Affolter et al., 2009). To this end, nutrigenomics attempts to integrate the 
“omics” technologies (genomics, transcriptomics, epigenomics, metabolomics) in addition 
to post-translational modifications (Affolter et al., 2009; Liu and Qian, 2011). Personalized 
(genomic) medicine exploits genomic information in the context of guiding medical 
decision-making, thereby allowing physicians to make assessments of disease risk and 
design rational evidence-based treatment regimens. For this, the unique genomic profile of 
an individual has to be taken into consideration alongside their clinical profile to achieve a 
health-oriented decision (Pavlidis et al., 2012). However, being an emerging discipline, 
personalized medicine has yet to attain wide applicability in modern medical practice. 
Nutrigenomic testing refers to the testing of genes that relate to conditions that are 
influenced by nutrition. To date, nutrigenomic testing is mostly provided using the direct-
to-consumer (DTC) business model and given the fact that there is currently very limited 
information on its clinical validity, it is dealt with skepticism from the scientific 
community (Gulisano, 2013). This situation differs from pharmacogenomics and genetic 
testing of single gene disorders, where genotype-phenotype correlations are well 
established (Patrinos et al., 2013). To date, a large number of private genetic laboratories in 
several countries are providing nutrigenomic testing of several genomic variants that have 
been shown to be related with dietary intake and nutrition-related pathologies. Considering 
the fact that there are often contradictory findings as to whether these genomic variants can 
be correlated with such pathological inherited conditions, we sought to determine which 
ones of these genomic variants can indeed be correlated with such inherited conditions and 
as such have a true prognostic nutrigenomic value.  
Herein, a thorough literature search and meta-analysis of 38 genes analysed in 
commercially available nutrigenomic tests were conducted in an effort to highlight or 
overrule their prognostic value, questioning their use in nutrigenomic testing. In particular, 
we aimed to address whether: (a) these genes were indeed associated to various 
nutrition/food-related pathologies/diseases, (b) there were any solid clinical-evidenced 
guidelines on the use of the nutrigenomic tests available, (c) scientific results and 
indications validate the relationship between each gene or group of genes and the various 
nutrition/food-related diseases, and (d) the existing research literature could be used by 
healthcare professionals for diet/nutrition and medical testing and therapy purposes based 
on the results available to date. 
 
Methods 
A thorough search was conducted in the PubMed literature database for genotype-
phenotype correlation studies on 38 genes using the following terms: “nutrigenomics”, 
“gene name” and “disease name” (Table 1). The 38 genes of interest were chosen 
following research on commercially available nutrigenomics tests and their specifics. Our 
meta-analysis included 1,170 entries published from 1995 to 2012. In total, 524,952 
individuals (361,153 patients and 163,439 healthy individuals) from various ethnicities 
were considered. Related pathologies included obesity, diabetes, insulin resistance, 
hypertension, metabolic syndrome and gastrointestinal diseases (ulcerative colitis, crohn’s 
disease, HP, etc.). We focused on the genes of interest and their genomic variants (SNPs, 
indels, etc), the number of patients (cases) and controls, the date and type of study (single-
gene and genome-wide association study), the location and population details (e.g. gender, 
race/population, etc), groups’ age, the phenotypic measures included, the allele and 
genotype frequencies as well as the overall outcome of each study. Diseases and conditions 
were grouped accordingly:  
1. Cardiovascular Group (including ischemia and stroke) 
2. Liver (hepatic) Group 
3. Obesity Group 
4. Metabolic syndrome, Diabetes and Insulin Resistance Group. 
5. Lung and Respiratory Group 
6. Cancer Group 
7. Bone Disease Group 
8. Lipid Group 
9. Autoimmune Disease Group 
10. Gastrointestinal Group 
11. Anthropometry Group 
12. Nephrology Group 
13. Vascular Group 
14. Neurology Group 
15. Nutrient Group 
16. Inflammation Group 
17. Any other condition not included above 
Data analysis occurred according to four different models due to data sparsity and 
inconsistency (Table 2). 
 
Data mining and preprocessing 
Data mining techniques were used to automatically obtain groups of SNPs or 
conditions that showed similar clustering according to the available association data. For 
all the genomic variants considered, the nature of their link with a condition was qualified 
by qualitative terms, such as: ‘yes’, ‘may’, ‘no’ and ‘unknown’ (Table 3). Then, the data 
derived from all studies and for every genomic variant were combined into a single record, 
called the ‘variant phenotypic profile’. Similarly, a ‘genotype profile’ was generated for 
each condition. 
Initial examination of the phenotypic profiles revealed that they were very sparse 
since only a fraction of possible variant/condition associations had been reported in the 
literature. In addition to data sparsity, many inconsistencies between studies were 
observed. Since data sparsity and inconsistency are issues that cannot be ignored, they 
were taken into account in the design of the analysis methodology. Not only did we 
conduct an initial analysis attempting to identify similarities between phenotype and 
genotype profiles, but we also decided to reduce the impact of sparsity by performing 
further data exploration at a lower resolution. Although this might lead to a reduction of 
accuracy, manual inspection of novel patterns emerging from data mining should prevent 
any undesirable effect of the analysis protocol. First, we worked at the gene level: all 
studies of SNPs related to a given gene were merged into a single profile, called the ‘gene 
phenotype’. Secondly, diseases and conditions were also grouped according to similarity 
for analysis purposes. A summary of the number of studies/results per model/analysis 
methodology is provided in Table 2.  
Whatever the type of data, phenotypic and genotypic profiles were analysed to 
detect similarities between them. Note that we also investigated variants/genes displaying 
opposite effects. As in our previous work (Lanara et al., 2013), profile comparison and 
grouping were performed using a state-of-the-art data-mining tool, CLUTO (Rasmussen et 
al., 2003). More specifically, hierarchical agglomerative clustering was carried out to 
produce a binary tree representing similarities between profiles and highlighting possible 
groupings. Finally, the most informative groups were further analysed using the STRING 
9.1 (http://string-db.org) database to collect additional evidence of associations. 
A comprehensive list of supplemental references supporting the meta-analysis is 
presented under the supplemental materials section. 
 
Results 
Phenotypic Profiles 
As anticipated, phenotypic profiles proved to be very sparse: despite 153 different 
genomic variants and 89 conditions were considered, only 679 different associations were 
revealed, i.e. 5% of the possible 13,617 associations. Since most associations have not 
been studied, our conclusions should be considered with extra caution. Moreover, a great 
number of inconsistencies were identified: in regards to the entire number of studies 
researched, 20% of the genomic variants displayed inconsistent phenotypic profiles, 
whereas an additional 64% relied on results which have never been reproduced. Similarly, 
33% of the conditions studied exhibited inconsistent results and 46% consisted of 
unreproduced associations. As expected, the aggregation of SNP profiles into ‘gene 
phenotype’ and grouping of diseases and conditions led to significant reductions of data 
sparsity from 95% to 88% and 68% ‘unknown’ associations, respectively, and an increase 
in data inconsistency (Table 4).  
In the case of genomic variants with identical/similar phenotypes, our analysis 
revealed two IL6 variants, namely rs1800797 and rs1800796. Identical/similar phenotypes 
for given conditions/diseases were also obtained for the APOA1, APOA4, PON1, APOC3, 
MTHFR, APOA5 and CRP genes. This was not true for the phenotype profiles regarding 
PON1 and PON2 genes. At the gene level, new associations were obtained when the 
following comparisons were performed: LIPC vs LDLR vs APOE, LDLR vs APOE, LDLR 
vs LIPC, LIPC vs APOE, UCP3-2 vs UCP2, MTHFR vs MTR vs MTRR and LPL vs 
ADRB2. Focusing on the resulting groups of conditions, only two similar conditions were 
obtained: (i) HMGCR (rs4704209, rs3761739, rs5909, rs3761738, rs17238540, 
rs10038095, rs3846663, rs2303152) was found to be related with the condition groups 4, 7 
and 13 (metabolic syndrome, diabetes and insulin resistance group; bone disease group and 
vascular group respectively) and (ii) LDL (rs6413503) and APOE (rs440446) with groups 
1, 9, 17 (Cardiovascular group, autoimmune disease group and other group respectively). 
When genes with similar phenotypes were investigated in regards to the condition groups, 
we have found that all clusters associations were quite weak (two out of the 17 groups). 
This was the case for the APOA2 vs ABCC6 vs APOC4 vs RXRA vs CUBN genes and may 
be explained by the evidence of interaction between APOA2, APOC4 and RXRA. It should 
be noted that the genes FABP2 vs CYP7B1 vs MTP and the PPARA vs IL8 also showed 
some associations to specific groups. 
Data inconsistency for all options/models of analysis 
Herein, data inconsistency was profound.  In brief, incompatible data were obtained 
for IL6 (rs1800795 and rs1800796) as well as ADRB3 genes (when searched at the gene 
level and the rs4994 level). Additionally, in the case of the ADRB2 gene, 4 out of the 16 
conditions were found incompatible, when we investigated ADRB2 (rs1042714) in 26 
studies, while 4 out of 10 incompatible conditions in 17 studies were found for ADRB2 
(rs1042713). Regarding the CETP gene, data showed 7 out of 18 incompatible conditions 
in the 113 studies studied. When the CETP was researched at the SNPs level (rs5882, 
rs708272, rs1800775), the outcome was similar. Notably, the CRP gene was found in 84 
studies, among which 3 out of the 20 conditions studied were found to be incompatible. 
This is quite a low number, which needs to be further investigated and included in future 
metanalyses. At the SNPs level (rs1130864), only 1 condition in the 18 studies was found 
to be incompatible, while CRP (rs1205) has a high value and no incompatibility has been 
published, indicating straightforward single SNP associations. Additionally, the APOA5 
gene resulted in 3 out of 10 incompatible conditions in 47 studies and in 1 out of the 7 
incompatible conditions in 11 studies, when the APOA5 (rs2075291) was considered. 
Finally, two incompatible conditions were found in each one of the APOC3, GSTP1, LIPC, 
LPL, PON1, TNF and UCP2. Similar results were obtained when these conditions were 
investigated at the SNPs level.  For the MTHFR gene, 1 out of the 14 conditions was found 
to be incompatible in 29 studies, which certainly requires further investigation.  The SNPs 
of interest as well as their positive or negative association to the diseases/conditions 
studied is shown in Figure 1.   
Non-incompatible results among the four options/models of research 
Among the genes and their respective SNPs that we investigated in the various 
studies considered herein, there were many conditions, which were investigated devoid of 
incompatible results. However, due to the small amount of studies in some cases, we 
suggest that these points should be investigated further in a new meta-analysis by taking 
into account any new genome-wide association studies (GWAS) papers to include various 
and numerous populations. Notably, (i) HMGCR, PPARA and IL8 genes (when all 3 were 
investigated at the gene level), (ii) CRP (when considered at the SNPs level), (iii) MTRR 
(gene and SNPs levels), (iv) MTR (gene and SNPs levels), (v) TNF SNPs level) and (vi) 
IL6 genes (SNPs level) showed no incompatible results in a higher number of studies per 
condition (gene and/or SNPs level) ranging from 1.1 to 7 studies per condition.  
Indeed, when looking at the datasets analysing the links of diseases/conditions to 
genes and/or SNPs, various points of interest were obtained. In the case of cardiovascular 
diseases/conditions we have found incompatibility among conditions and diseases such as 
coronary vasculopathy, hypertension, essential hypertension acute or not acute myocardial 
infraction, ischemic stroke and coronary heart disease. However, the incompatibility varied 
according to the number of total studies researched. As an example, in the case of coronary 
heart disease and hypertension, 1 gene out of the 2 researched was found incompatible in a 
total of 6 studies investigated, while in the case of essential hypertension incompatibility 
was found in 2 out of the 5 genes researched in the 25 studies regarding cardiovascular 
diseases that were investigated in our meta-analysis. In the case of gastrointestinal diseases 
and conditions, when 3 genes investigating celiac disease were studied in 10 studies, two 
of them were showed incompatible results. On the other hand, other gastrointestinal 
conditions such as crohn’s disease, ulcerative colitis, helicobacter pylori, duodenal ulcer, 
esophageal cancer and its complications showed no incompatibility, however there was 
only 1 study per condition. In the case of conditions/diseases such as weight/obesity/ lipid 
levels and various metabolic syndrome parameters (BMI, HDL-C, weight gain, 
triglycerides, visceral fat, abdominal adiposity, higher value of hip circumference, higher 
values of HDL-C, lower waist/hip ratio, metabolic syndrome, high plasma of cholesterol 
were researched), similar points were addressed except for the lack of incompatibility 
when the metabolic syndrome and the three genes researched were considered (among the 
18 studies investigated). There was also a slight difference in regards to glucose and 
insulin conditions/diseases (glucose/insulin/diabetes/ insulin resistance/plasma insulin 
levels/elevated glucose levels/ gestational diabetes mellitus and carbohydrate metabolism), 
where studies per gene/SNP were ranging from 1 to 2.8. Finally, cervical cancer seems to 
be an emerging important result, although this is a non-nutrigenomic condition. Instead, its 
evaluation was encouraged, as it was investigated in many of the studies described herein. 
Indeed, the link to cervical cancer was investigated in two genes in 13 studies, leading to 
6.5 studies per gene. This outcome should be further investigated in a meta-analysis of 
cancer genes. Lastly, regarding the link to SLE, there were only 1 to 1.4 studies per 
SNP/gene, indicating that further research is also needed. 
 
The outcome on the diseases/conditions studied and the resulted associations with 
obesity, weight gain, insulin sensitivity-resistanse, diabetes and glucose levels 
 
Regarding obesity, only 1 study showed a positive result when the association of 
the ADRA2B gene and obesity was investigated, being however population-specific. No 
links were found to weight gain, while the rest of the studies focused on traits, such as 
CVD, hypertension, insulin secretion, type 2 diabetes, heart rate, physical activity, diet and 
incident diabetes, anthropometric and metabolic phenotypes, essential hypertension with or 
without type 2 diabetes mellitus, metabolic syndrome, sudden cardiac death and silent 
myocardial ischemia. In terms of the ADRB3 gene and obesity only conflicting results were 
obtained, whereas only one study showing no link to obesity was obtained for CRP.  
Regarding diabetes, five studies showed positive and negative links to the disease among 
which one study revealed conflicting results.  No link was found in the only study 
researching IRS -1 and type 2 diabetes. In the case of the IL6 gene and diabetes, it seems 
that a positive link exists, however this refers to only three studies.  In addition, only one 
study showed a positive association between PON1 and diabetes and ApoA1 and diabetes, 
whereas a negative association was revealed, when ABCA1 was studied. A study for the 
GSTT1 and GSTM1 investigating their link to type 1 diabetes showed no association. Data 
on LPL and UCP3 imply a link to insulin sensitivity. Another study investigated the 
possible association between insulin resistance and APOA5 and showed no association. On 
the other hand, one study showed a ‘small yes’ association between LPL and insulin 
resistance and two studies a ‘may’ association between UCP2 and UCP2-3, while another 
study showed a positive association between ADRB1 and diabetes type 2. No association 
was found between ADRA2A and diabetes in one study, whereas a positive association was 
obtained between ADRA2B and diabetes type 2. Finally, only one study showed no 
association between the fasting glucose levels of ADRA2A and glucose levels. Notably, 
there were conflicting results for the CRP gene and negative association data for IL1a and 
IL6. Conflicting results were also obtained for SLC30A8 and TLCFL2. 
 
Gastrointestinal conditions/diseases  
Regarding the gastrointestinal conditions and diseases, one study showed 
conflicting results on TNF and ulcerative colitis as well as a negative link between the 
latter and HLA. The IL10 showed negative results, while for the IL1 gene conflicting 
results were shown for Helicobacter pylori. In the case of the TNF gene, there were more 
negative results for Helicobacter pylori and only one study showing positive results for the 
-308AG genotype. No link to gastric ulcer was found among the studies considered.  
 
STRING software analysis 
 
When the relationships between ADRB1-ADRB3 and ADRA1A-ADRA1B were 
investigated, a strong association was obtained. Similar findings were obtained for SOD2 
and SOD3. These results were not found in our meta-analysis. In brief, the conflicting 
results are shown in Supplementary Figures 1-5. Additionally, the absence of statistical 
association between genes/SNPs and condition/diseases group is depicted in 
Supplementary Figure 6. Data incompatibility is summarised in Tables 3 and 4. Finally, a 
representation of the number of studies per genes researched for certain diseases and 
conditions are found in Supplementary Figures 7-21. 
 
Discussion 
 
The need to investigate the field of nutrigenomics via a meta-analysis approach 
arose since our group started noticing that extensive literature was published throughout 
the years regarding nutrigenomics analysis, nutrigenomics tests and gene/ variations 
interactions with diseases influenced by nutrition. However, research studies were so far 
discontinuous and thus, not many final conclusions were made for diseases/conditions 
and/or nutrients of interest. There were sparse results and various single referenced studies, 
assuming that certain genes/mutations were associated or not to certain diseases and 
conditions emerged. Finally, the lack of regulation shows that there are no specific 
recommendations and guidelines till now in order to apply these tests in everyday life. It 
seems also that health professionals, but also in some cases the general public, are not 
totally ready for the use of these tests or they cannot fully understand or interpret them 
(Pavlidis et al., 2012). The need for an enhanced education/training on this field as well as 
data interpretation became evident in our previous study on nutrigenomics perceptions and 
views in Greece (Pavlidis et al., 2012). On the other hand, extra care should be given when 
these tests are prescribed, as their use is not yet well defined by law and by the scientific 
community through clinical research.  
The trend of DTC and nutrigenomics testing is becoming more known to our 
society. Patrinos and co-workers (2013) discussed the various categories of genetic testing, 
one of which includes genetic tests designed to diagnose complex health conditions 
(Patrinos et al., 2013). In these tests, as described, where a risk for obtaining false-positive 
or false negative results is high, misinterpretation could often occur. Extra care should be 
given as misinterpretation could lead to an increased cost of the diagnostic procedures 
used, which were not probably needed or have the opposite effect (Patrinos et al., 2013). In 
the latter case, the individual becomes less vigilant about their health. At this point, we 
should not forget that there are very few qualified healthcare professionals to interpret the 
nutrigenomics tests results to individuals from the general population. As a consequence, 
results may not be well perceived, understood and even be acted on. Nevertheless, there is 
a tendency in believing that personalised nutrition would be more helpful (Pavlidis et al., 
2012; Hurliman et al., 2014).  
Direct to consumer testing is defined as the sale and use of genetic testing that does 
not include the involvement of the health care provider (Goddard et al., 2008). Companies 
offering such tests via the Internet, pharmacies and in any other commercial way are 
spread worldwide and grow rapidly. An increase of DTC genetic tests from 14 to 84 
instances (or 53 unique tests) was shown from a study in 2008 (Thompson et al., 2011) in 
only four years. Among those tests, nutrigenomics testing was also largely included.   
The findings of our analysis are limited, however, there are important points 
highlighted which may benefit from futher investigation, when new research arises with 
more GWAS studies included. There were very few associations and in some cases, they 
were based on a few studies, such as one or two studies per gene or snp or condition. In 
some limited cases, we have found associations that were not expected, whereas in many 
cases there were conflicting results. When looking at the literature for the genes usually 
found in nutrigenomics testing and via various companies offering DTC genetic tests on 
nutrigenomics, we have noticed that, generally, no clear association was supported by the 
existing scientific evidence. Indeed, we have grouped the genes involved in the 
nutrigenomics tests analysed mainly according to diseases and conditions and not to the 
effect of the nutrients to a specific disease or condition (we have found very few studies on 
these points), as we have not found many studies on these associations. For instance, it is 
widely known that ω-fatty acids help against the risk factors of CVD, however, we have 
not found many studies that investigated the role of these fatty acids according to the 
genomic variants carried by the individuals. It should be noted that the field of 
nutrigenomics is highly complex, as it relies on nutrients, conditions and diseases, medical 
history and also eating habits, as well as genes. Our study, to our knowledge, is one of the 
very few to investigate and apply a meta-analysis for thirty-eight genes usually involved in 
nutrigenomics from a of diseases point of view that are mainly influenced by nutrition. 
Today, there is a lot more to be investigated and this study sets the pace for further 
research on all genes involved in nutrigenomics with more GWAS studies, as these will be 
more useful by including more individuals. We have found a limited amount of GWAS 
through our literature search and of course, this is a starting point for the future 
investigation of genes involved in nutrigenomics that will help the future of designing 
personalised nutrition, personalised diets as well as personalised medical nutritional 
therapy through the effect of the nutrients, the genes and the SNPs involved.  
Diseases/pathologies such as obesity, diabetes, cardiovascular conditions, metabolic 
syndrome, gastrointestinal conditions as well as factors (weight, BMI), but also lipid 
levels, cholesterol and triglyceride levels, would all possibly be aided by the use of 
nutrigenomics, when further research is available. The research and scientific community 
supports that in the field of nutrigenomics more should be done in the models of applying 
this science for personalised nutrition (Gulisano, 2013; Ordovás Muñoz, 2013). Different 
types of diets, using various methods, such as the blood type and diet combination are not 
supported by research (Wang et al., 2014). It is true that another study focusing on the 
PPAR, ADRB2, ADRB3, IL6, LIPC, LEP, LEPR and UCP3 genes led to variable results, 
when looked at their association to obesity and the outcome of fat restricted diet (Martinez 
et al., 2008). Additionally, one review showed a metabolic response to omega3 fatty acid 
supplementation for the APOE genotype and age/gender/BMI (Thifault et al., 2013). All 
these results in a whole show that there is a lot yet to be researched and the field of 
personalised diet and nutrition is ready for more studies designed in large mixed 
populations in order to include all possible genetic variations and polymorphisms.  
The fact that nutrigenomics is a wide field that involves 
genes/mutations/conditions/diseases/food/nutrients etc, does not allow in such a 
preliminary state to proceed to the use of nutrigenomics testing in the general public. This 
is also stated by the position of the American Academy of Nutrition and Dietetics in 2014 
(Camp and Trujilo, 2014), which identifies the problems in applying in such an early state 
without specific research on nutrigenomics, the use of nutrigenomics testing for the 
treatment of diseases/conditions. In fact, this position states that mutations are only 
partially predictive of disease risk and shows the lack of education of the dietitians to 
interpret such results. Many years would be probably needed in order to have definite 
results clinically and scientifically proven, which will then be applied to our everyday life 
and the future era of personalised medicine and nutrition. It would be a great scientific 
progress in the clinical field if we could treat patients according to their genes, mutations 
and have hands-on experience of how nutrient and diet interacts with them and the person 
itself.  
 
Conclusions 
 
The present study, involving meta-analysis of over half a million cases, indicated 
that there are conflicting findings and a great incompatibility as far as associations between 
genomic variants with nutrient-relate pathologies and dietary intake are considered. In the 
vast majority of cases, there was no statistically significant association for any of the 38 
genes of interest, whereas even in the very few cases where a weak association was found, 
this was based on a very limited number of studies. We feel that nutrigenomic testing 
should not be yet provided as a commercial service by genetic laboratories, as solid 
scientific evidence is currently lacking for the genomic basis of nutrient-related 
pathologies and phenotypes. Notwithstanding, continuous research will allow patients’ 
treatment according to their genomic variants and their interactions with nutrients and diet. 
In this context, metabolomics and in particular, nutri-metabolomics data as well as multi-
omics data integration are anticipated to play a key role (Mounayar et al., 2014; Montague 
et al., 2014).  
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List of Abbreviations 
 AA: advanced atherosclerosis  
 AASK: African-American Study of 
Kidney Disease and Hypertension 
 ACS: Acute Coronary Ischemia 
 ACS: acute coronary syndrome (s) 
 AMI: acute myocardial infarction 
 BC: breast cancer 
 BMD: bone mineral density 
 BRCA: breast cancer risk 
 CAC: carotid artery compliance 
 CAGB: coronary artery bypass graft 
 CAD: coronary artery disease  
 CD: celiac disease 
 CHD: coronary heart disease 
 CHF: chronic heart failure 
 CIMT: carotid intima media thickness 
 CKD: chronic kidney disease 
 COPD: chronic obstructive pulmonary 
disease  
 CRC: colorectal cancer 
 CRC: Colorectal Cancer 
 CRI: chronic renal insufficiency 
 CV: coronary vasculopathy 
 CVD: cardiovascular disease 
 DN: diabetic nephropathy 
 DPN: diabetic polyneuropathy 
 EH: essential hypertension 
 ESRD: end-stage renal disease  
 FCH: familial combined 
hypercholesterolemia 
 FH: familial hypercholesterolemia 
 FMD: brachial artery flow-mediated 
vasodilatation 
 GC: gastric cancer 
 GH : gestational hypertension,  
 GPL: gastric pre-cancerous lesions 
 HALP: Hyperalphalipoproteinemia  
 HCC: hepatocellular carcinoma 
 HRV: Heart rate variability 
 IBD: inflammatory bowel disease 
 IHD: ischemic heart disease 
 IMT : carotid intima-media thickness 
 IPF: Idiopathic Pulmonary Fibrosis 
 IS: ischemic stroke 
 MI: myocardial infraction 
 MS: metabolic syndrome 
 NAFLD: Non-alcoholic fatty liver 
disease  
 NASH: non-alcoholic steatohepatitis 
 OA: osteoarthritis 
 PAD: peripheral arterial disease 
 PD: Parkinson’s disease 
 PDB : Paget’s disease of bone 
 PDR: proliferative diabetic retinopathy 
 PE: preeclampsia  
 PSA: psoriasis 
 RA: rheumatoid arthritis 
 RA: rheumatoid arthritis 
 RCR: renal cancer risk 
 tHcy : plasma homocysteine 
 VAHC: Veterans Affairs Hypertension 
Cohort  
 VTE: venus thromboembolism 
 UC: ulcerative colitis 
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Figure Legend 
 
Figure 1.  
The positive or negative association of the SNPs of interest to diseases/conditions. Our 
analysis show that associations are generally unknown and when genes or SNPS are 
showing similar profiles those only rely on very few known associations. Note that SNPS 
are organised according to similarity in terms of condition associations. Rows show genes 
or SNPS of interest, whereas columns show conditions or condition groups.White block (or 
light green/red): no or unclear information regarding potential association. Green block: 
positive association. Red block: negative association. Shades of green and red show how 
strong the association is. 
 
 
Tables 
Table 1. Search criteria for gene and disease/ pathological condition association 
Genes Disease/Pathological condition: investigation of 
possible association 
APOA1, APOA5, APOB, 
APOC3, APOE 
Cardiovascular disease, Coronary heart disease, 
Coronary artery disease, Hypercholesterolemia 
CETP 
Cardiovascular disease, Coronary heart disease, 
Coronary artery disease, Hypercholesterolemia, Diabetes 
GJA4 (CX37) 
 
Atherosclerosis, Hypertension, Stroke, Coronary artery 
disease 
HMGCR 
 
Hepatic disease, Non- alcoholic fatty liver 
LIPC 
Hepatic disease, Hypercholesterolemia, Fatty acid 
metabolism 
LPL 
Dyslipidemia, CVD, Metabolic syndrome 
PON1 
 
Atherosclerosis, Diabetes, Metabolic syndrome 
CAT 
 
Diabetes, Hepatic diseases, Kidney diseases  
GPX1 
Various types of gastrointestinal cancer 
GSTM1 
 
Various types of gastrointestinal cancer, Various types of 
gastrointestinal disease, Coronary artery disease 
GSTP1 
 
Various types of gastrointestinal cancer, Various types of 
gastrointestinal disease, Coronary artery disease 
GSTT1 
 
Non-alcoholic fatty liver disease, Various types of 
gastrointestinal cancer, Various types of gastrointestinal 
disease, Coronary artery disease 
MNSOD 
 
Various types of gastrointestinal cancer, Coronary artery 
disease, Various types of gastrointestinal disease 
SELS 
 
Diabetes, Various types of gastrointestinal disease 
various types of gastrointestinal cancers, Metabolic risk 
factors 
SOD2 & SOD3 
Coronary Artery Disease, Chronic Obstructive Pumonary 
Disease 
EPHX1 
 
Chronic obstructive pulmonary disease, Various types of 
gastrointestinal cancer, CVD, Stroke 
UCP2 
Diabetes, Obesity, Abdominal obesity, Hyperinsulinemia 
AGT 
Coronary artery disease, Chronic kidney disease 
CBS 
Celiac disease, Hyperomocystenaemia, Homocysteine 
metabolism 
COMT 
Parkinson’s disease, Schizophrenia 
MTHFR 
 
Homocysteine metabolism, Coronary artery disease, 
Cardiovascular disease, Coronary heart disease 
MTR 
 
Coronary artery disease, Rheumatoid arthritis 
MTRR 
Homocysteine metabolism, Coronary artery disease, 
Cardiovascular disease, Coronary heart disease, 
Reuhmatoid arthritis, Folate and choline metabolism 
TCN2 
To our knowledge there were no data that could be 
analysed at the moment that the metanalysis occured. 
CRP 
Body mass index, Obesity, Atrial fibrillation, Coronary 
heart disease, Diabetes, Inflammation/ Inflammatory 
response 
IL-6 
 
Coronary heart disease, Inflammation/ inflammatory 
response 
TNF 
Inflammation/Inflammatory response, Coronary artery 
disease, Weight regain, Acute pancreatitis, Gastric cancer 
and various types of gastrointestinal cancer 
ADRB2 
Hypertension, Acute coronary syndrome, Obesity, 
Cardiovascular diseases, Metabolic syndrome 
ADRA2A 
 
Ischemic stroke, Diabetes, Cardiovascular diseases, 
Obesity, Metabolic syndrome 
ADRB1 
 
Coronary heart disease, Diabetes, Obesity, Hypertension, 
Metabolic syndrome 
ADRA1B 
Coronary heart disease, Diabetes, Obesity, Hypertension, 
Metabolic syndrome 
ADRB3 
Coronary heart disease, Diabetes, Obesity, Hypertension, 
Metabolic syndrome 
ADRA1A 
 
Coronary heart disease, Diabetes, Obesity, Hypertension, 
Metabolic syndrome 
 
 Table 2. Number of studies showing incompatibility in all four models of analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please note that in option/model of analysis 3, no incompatibility was found. (NA, not available) 
 
 
 
 
 
 model  1  
 
(conflicting 
association 
to 
conditions) 
model  1  
 
(conflicting 
association 
to SNPs) 
model   2  
 
(conflicting gene 
association to 
conditions) 
model   2  
 
(conflicting 
association to 
genes) 
model   3  
 
(SNPs per 
condition 
groups) 
model  4  
 
(conflicting gene 
association to 
condition groups) 
model  4  
 
(conflicting 
association 
to genes) 
Incompat
ible 
results 
31 29 17 31 NA 17 13 
Compatib
le results 24 19 14 20 NA 13 3 
Compatib
le results 
(very few 
studies 
per gene 
or SNP) 
98 41 14 9 NA 14 NA 
Table 3. An analytical representation of the incompatible results of genes with their 
respective nomenclature (and the rs numbers found in the studies researched) to 
condition groups, * «yes» or «no»  
 
Gene 
dbSNP 
id 
condition groups 
with incompatible 
results (*) 
number of 
studied condition 
groups 
number 
of 
studies 
average number 
of studies per 
condition group 
IL6  11 12 176 14.7 
CETP  8 11 118 10.7 
ADRB3 rs4994 7 10 41 4.1 
ADRB2  5 9 54 6.0 
TNFA  5 9 65 7.2 
CRP  4 13 111 8.5 
APOA5  3 9 51 5.7 
LIPC  3 8 29 3.6 
APOC3  2 9 34 3.8 
GSTP1 rs1695 2 4 12 3.0 
LPL  2 8 22 2.8 
MTHFR  2 11 34 3.1 
PON1  2 9 45 5.0 
UCP2  2 8 26 3.3 
DGKB rs2191349 1 1 2 2.0 
MTRR rs1801394 1 9 15 1.7 
PON2  1 5 11 2.2 
 
Table 4. Incompatibility of condition groups in relation to the genes, * «yes» or «no».  
 
group 
number 
group description 
genes with 
incompatible 
results (*) 
number 
of 
genes 
number 
of 
studies 
average 
number of 
studies/gene 
GROUP 1 
Cardiovascular group 
(including ischemia and 
stroke) 
9 32 148 4.6 
GROUP 4 
Metabolic syndrome, 
Diabetes and Insulin 
Resistance group 
8 26 171 6.6 
GROUP 13 Vascular group 7 15 76 5.1 
GROUP 17 Other' group 7 18 73 4.1 
GROUP 3 Obesity group 5 16 88 5.5 
GROUP 6 Cancer group 5 19 101 5.3 
GROUP 7 Bone disease group 5 28 155 5.5 
GROUP 10 Gastrointestinal group 4 7 26 3.7 
GROUP 5 
Lung and Respiratory 
group 
3 19 47 2.5 
GROUP 16 Inflammation group 3 9 46 5.1 
GROUP 8 Lipid group 2 7 22 3.1 
GROUP 12 Nephrology group 2 6 23 3.8 
GROUP 11 Anthropometry group 1 11 23 2.1 
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Supplementary Figure 1. Conflicting gene association to condition (incompatible results). 
Numbers next to the genes show the number of studies per gene. 
 
 
Supplementary Figure 2. Conflicting associations to conditions (incompatible results). 
Numbers next to the genes show the number of studies per gene/SNP. 
 
Supplementary Figure 3. Conflicting SNPs associations to links (incompatible results). 
The number of SNPs is shown vertically. The names of the links of diseases and conditions 
per SNP are shown horizontally. 
 
Supplementary Figure 4. Conflicting gene associations to links (incompatible results). 
The number of genes is shown vertically. The names of the links of diseases’ and 
conditions’ groups per total number of genes are shown horizontally. 
 
Supplementary Figure 5.  Conflicting gene associations to links (incompatible results) to 
diseases and conditions. The number of genes is shown vertically. The names of the links 
of diseases and conditions are shown horizontally. 
Supplementary Figure 6. Genes/SNPs and pathological conditions/diseases groups. The 
group names that correspond to the group numbers shown can be found in suppl. figure 1. 
The black colour shows no statistical association between the SNPs and the pathological 
conditions/diseases groups. 
  
Supplementary Figure 7. Conflicting results (number of studies) for the APOA5, CETP, 
IL6 and MTHFR genes and their link to CAD (n=17929, 18: «yes», 14: «no», 4: «may»). 
Supplementary Figure 8. Conflicting results (number of studies) for the PON1, LIPC and 
CETP genes and their link to CHD (coronary heart disease) (n=6119, 6: «yes», 9: «no», 4: 
«may»). 
 
Supplementary Figure 9. Conflicting results (number of studies) for CRP, LIPC and IL6 
genes and their link to CVD (n=31527, 21: «yes», 4: «no», 12: «may») 
 
Supplementary Figure 10. Conflicting results (number of studies) for the CRP and IL6 
genes and their link to CRP levels and insulin resistance or only CRP levels (n=4199, 5: 
«yes», 5: «no»). 
 
Supplementary Figure 11. Conflicting results (number of studies) for the ADRB3, 
APOA5, APOC3 and CRP genes and their link to triglycerides (n=28528, 24: «yes», 10: 
«no», 11: «may»). 
 
Supplementary Figure 12. Conflicting results (number of studies) for the ADRB3 and 
CRP genes and their link to obesity (n=3809, 3: «yes», 5: «no»). 
 
Supplementary Figure 13. Conflicting results (number of studies) for the UCP2 and 
CETP genes and their link to BMI (n=2753, 2: «yes», 9: «no», 1:«may»). 
 
 
Supplementary Figure 14. Conflicting results (number of studies) for the ADRB2 and 
UCP2 genes and their link to diabetes (n=3131, 4: «yes», 3: «no»,) 
 
Supplementary Figure 15. Conflicting results (number of studies) for the ADRB2 and 
UCP2 genes and their link to HDL-C (n=43989). 
 
Supplementary Figure 16. Conflicting results (number of studies) for the ADRB2 and 
UCP2 genes and their link to metabolic syndrome (n=4599, 2: «yes», 9: «no»). 
 
Supplemenary Figure 17. Conflicting results (number of studies) for the LIPC gene and 
its link to total cholesterol (n=8583, 2: «yes», 6: «may»). 
 
Supplementary Figure 18. Conflicting results (number of studies) for the ADRB2 gene 
and its link to total fat (n=1250, 1: «yes», 3: «no») 
 
 
Supplementary Figure 19. Conflicting results (number of studies) for the ADRB2 and 
ADRB3 genes and their link to subcutaneous fat distribution (n=1509, 2: «yes», 4: «no»). 
 
 
Supplementary Figure 20. Conflicting results (number of studies) for the ADRB2 and 
ADRB3 genes and their link to abdominal adiposity (n=2446, 2: «yes», 4: «no»). 
 
Supplementary Figure 21. Conflicting results (number of studies) for the ADRB2 gene 
and its link to hypertension (n= 8643, 2: «yes», 4: «no»). 
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